Citi lowered the firm’s price target on Core Laboratories (CLB) to $13 from $16 and keeps a Neutral rating on the shares. The firm updated models for a collection of Smid-cap oil and gas equipment and services stocks to incorporate updated rig count forecasts and recent earnings.
Meet Your ETF AI Analyst
- Discover how TipRanks' ETF AI Analyst can help you make smarter investment decisions
- Explore ETFs TipRanks' users love and see what insights the ETF AI Analyst reveals about the ones you follow.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on CLB:
- Core Laboratories N.V. Earnings Call Highlights Challenges and Strategic Gains
- Core Laboratories price target lowered to $13 from $15 at Stifel
- Core Laboratories Reports Q1 2025 Earnings Amid Challenges
- Core Laboratories reports Q1 EPS 14c, consensus 15c
- Core Laboratories sees Q2 EPS 17c-21c, consensus 19c